Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure

Clinical trial NCT01335932 · COMPLETED

Trial details

NCT number: NCT01335932
Sponsor: Fred Hutchinson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Lung Injury Acute Respiratory Distress Syndrome Respiratory Failure

Start date: 2011-03-10
Primary completion: 2016-06-17
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.